 
<prompt> National-Level Trends in IPTp 2+ | Percent of women age 15-49 with a live birth in the past two years who, during their last pregnancy, received atleast 2 or more doses of SP/Fansidar who received atleast one dose during an antenatal care visit. | (EDSB-III 2006, 3) (EDSB-IV 2011-2012, 23) (EDSB-V 2017-2018, 33) <response> One-third of women age 15-49 who had a live birth in the two years before the survey (33%) received two or more doses of SP/Fansidar, at least one during an antenatal visit. IPTp 2+ increased significantly from 3% in 2006 to 23% in 2011-2012 to 33% in 2017-2018.  